Real World CAR-T cell Therapy Outcomes in RR/MM with and without Cardiac Co-Morbidities: A Propensity Matched Database Study

Key Points

• CAR-T cell therapy outcomes show significant variation based on cardiac co-morbidities.
• The analysis used a propensity matched database framework to ensure comparability between groups.
• Outcomes were evaluated in patients with relapsed refractory multiple myeloma over a specific timeframe.
• Understanding these differences calls for tailored treatment strategies for patients with cardiac issues.